ESC: Novel Heart Failure Drug a Game-Changer (CME/CE)

(MedPage Today) -- An investigational heart failure drug being developed by Novartis cut deaths from heart disease by 20% compared with standard therapy, researchers reported today at the European Society of Cardiology. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1zWRelF